These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Kennedy's disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease. Breza M; Koutsis G J Neurol; 2019 Mar; 266(3):565-573. PubMed ID: 30006721 [TBL] [Abstract][Full Text] [Related]
4. Deterioration of muscle force and contractile characteristics are early pathological events in spinal and bulbar muscular atrophy mice. Gray AL; Annan L; Dick JRT; La Spada AR; Hanna MG; Greensmith L; Malik B Dis Model Mech; 2020 May; 13(5):. PubMed ID: 32152060 [TBL] [Abstract][Full Text] [Related]
6. Metabolic alterations in spinal and bulbar muscular atrophy. Francini-Pesenti F; Vitturi N; Tresso S; Sorarù G Rev Neurol (Paris); 2020 Dec; 176(10):780-787. PubMed ID: 32631678 [TBL] [Abstract][Full Text] [Related]
7. The French national protocol for Kennedy's disease (SBMA): consensus diagnostic and management recommendations. Pradat PF; Bernard E; Corcia P; Couratier P; Jublanc C; Querin G; Morélot Panzini C; Salachas F; Vial C; Wahbi K; Bede P; Desnuelle C; Orphanet J Rare Dis; 2020 Apr; 15(1):90. PubMed ID: 32276665 [TBL] [Abstract][Full Text] [Related]
8. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy. Adachi H; Waza M; Katsuno M; Tanaka F; Doyu M; Sobue G Neuropathol Appl Neurobiol; 2007 Apr; 33(2):135-51. PubMed ID: 17359355 [TBL] [Abstract][Full Text] [Related]
9. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA). Banno H; Katsuno M; Suzuki K; Tanaka F; Sobue G Cell Tissue Res; 2012 Jul; 349(1):313-20. PubMed ID: 22476656 [TBL] [Abstract][Full Text] [Related]
10. In Vitro and In Vivo Modeling of Spinal and Bulbar Muscular Atrophy. Pennuto M; Basso M J Mol Neurosci; 2016 Mar; 58(3):365-73. PubMed ID: 26614347 [TBL] [Abstract][Full Text] [Related]
11. Introduction to the Special Issue on Spinal and Bulbar Muscular Atrophy. Pennuto M; Gozes I J Mol Neurosci; 2016 Mar; 58(3):313-6. PubMed ID: 26875173 [TBL] [Abstract][Full Text] [Related]
12. [Kennedy's disease: expansion of the CAG trinucleotide]. Domitrz I; Jedrzejowska M; Lipowska M; Siddique T; Kwieciński H Neurol Neurochir Pol; 2001; 35(1 Suppl):107-14. PubMed ID: 11732276 [TBL] [Abstract][Full Text] [Related]
13. Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA). Katsuno M; Adachi H; Waza M; Banno H; Suzuki K; Tanaka F; Doyu M; Sobue G Exp Neurol; 2006 Jul; 200(1):8-18. PubMed ID: 16513111 [TBL] [Abstract][Full Text] [Related]
14. Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy. Thomas PS; Fraley GS; Damian V; Woodke LB; Zapata F; Sopher BL; Plymate SR; La Spada AR Hum Mol Genet; 2006 Jul; 15(14):2225-38. PubMed ID: 16772330 [TBL] [Abstract][Full Text] [Related]
15. [Anti-androgen therapy for spinal and bulbar muscular atrophy (SBMA)]. Katsuno M; Banno H; Suzuki K; Hashizume A; Adachi H; Tanaka F; Sobue G Rinsho Shinkeigaku; 2012; 52(11):1207-9. PubMed ID: 23196565 [TBL] [Abstract][Full Text] [Related]